Everolimus 0.25 MG Oral Tablet — RxCUI 977427
RxNorm drug concept · Semantic clinical drug
RxCUI 977427
Semantic clinical drug · SCD
● Current RxNorm concept 28 FDA products
40 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI977427
Official nameEverolimus 0.25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped28
Package NDCs mapped40
Reported Medicaid activity (SDUD)5,516 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Everolimus: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. Afinitor, Yulithira and generic everolimus tablets treat certain cancers and tuberous sclerosis complex conditions. Zortress and generic transplant table...
- Take it by mouth, the same way every time, either always with food or always without. The cancer and TSC products are usually once a day. The transplant products are usually twice...
- Mouth sores are very common, along with infections, rash, tiredness, diarrhea, swelling and low appetite. Mention mouth sores early, since they can be managed. Call your doctor rig...
- Check with me first. Many drugs change everolimus levels, including ketoconazole, clarithromycin, rifampin, St. John’s Wort and certain seizure medicines. Cannabidiol can raise lev...
🕸️ Concept Web — How Everolimus 0.25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Everolimus 0.25 MG Oral Tablet
RxCUI 977427 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Everolimus
141704IN
-
Everolimus
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zortress
977428BN
-
Zortress
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Everolimus Oral Tablet
845506SCDF -
Everolimus Oral Product
1163786SCDG -
Everolimus Pill
1163787SCDG -
Everolimus Oral Tablet [Zortress]
977430SBDF -
Zortress Oral Product
1186316SBDG -
Zortress Pill
1186317SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Everolimus Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Everolimus 0.25 MG
977426SCDC -
Everolimus 0.25 MG Oral Tablet [Zortress]
977431SBD -
Everolimus 0.25 MG [Zortress]
977429SBDC
-
Everolimus 0.25 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Everolimus 0.25 MG
SCDC · 977426 -
Everolimus Oral Tablet
SCDF · 845506 -
Everolimus Oral Product
SCDG · 1163786 -
Everolimus Pill
SCDG · 1163787
Brand-Name Concepts
-
Everolimus 0.25 MG Oral Tablet [Zortress]
SBD · 977431 -
Everolimus 0.25 MG [Zortress]
SBDC · 977429 -
Everolimus Oral Tablet [Zortress]
SBDF · 977430 -
Zortress Oral Product
SBDG · 1186316 -
Zortress Pill
SBDG · 1186317 -
Zortress
BN · 977428
📦 FDA Products & Package NDCs
28 products · 40 package NDCs
40 package NDCs map to RxCUI 977427 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0470-21 | 60 TABLET in 1 BOTTLE (0054-0470-21) | Everolimus | Hikma Pharmaceuticals USA Inc. | 2020-03-10 |
| 00054-0471-21 | 60 TABLET in 1 BOTTLE (0054-0471-21) | Everolimus | Hikma Pharmaceuticals USA Inc. | 2020-03-10 |
| 00054-0472-21 | 60 TABLET in 1 BOTTLE (0054-0472-21) | Everolimus | Hikma Pharmaceuticals USA Inc. | 2020-03-10 |
| 00054-0604-21 | 60 TABLET in 1 BOTTLE (0054-0604-21) | Everolimus | Hikma Pharmaceuticals USA Inc. | 2021-11-18 |
| 00078-0414-20 | 60 BLISTER PACK in 1 BOX (0078-0414-20) / 1 TABLET in 1 BLI... | Zortress | Novartis Pharmaceuticals Corporation | 2010-04-22 |
| 00078-0415-20 | 60 BLISTER PACK in 1 BOX (0078-0415-20) / 1 TABLET in 1 BLI... | Zortress | Novartis Pharmaceuticals Corporation | 2010-04-22 |
| 00078-0417-20 | 60 BLISTER PACK in 1 BOX (0078-0417-20) / 1 TABLET in 1 BLI... | Zortress | Novartis Pharmaceuticals Corporation | 2010-04-22 |
| 00078-0422-20 | 60 BLISTER PACK in 1 BOX (0078-0422-20) / 1 TABLET in 1 BLI... | Zortress | Novartis Pharmaceuticals Corporation | 2018-08-10 |
| 49884-0158-02 | 6 BLISTER PACK in 1 CARTON (49884-158-02) / 10 TABLET in 1... | Everolimus | Par Health USA, LLC | 2022-03-31 |
| 49884-0159-02 | 6 BLISTER PACK in 1 CARTON (49884-159-02) / 10 TABLET in 1... | Everolimus | Par Health USA, LLC | 2022-03-31 |
| 49884-0160-02 | 6 BLISTER PACK in 1 CARTON (49884-160-02) / 10 TABLET in 1... | Everolimus | Par Health USA, LLC | 2022-12-16 |
| 49884-0283-02 | 6 BLISTER PACK in 1 CARTON (49884-283-02) / 10 TABLET in 1... | Everolimus | Par Health USA, LLC | 2022-01-26 |
| 59651-0931-60 | 60 TABLET in 1 BOTTLE (59651-931-60) | everolimus | Aurobindo Pharma Limited | 2026-02-25 |
| 59651-0932-60 | 60 TABLET in 1 BOTTLE (59651-932-60) | everolimus | Aurobindo Pharma Limited | 2026-02-25 |
| 59651-0933-60 | 60 TABLET in 1 BOTTLE (59651-933-60) | everolimus | Aurobindo Pharma Limited | 2026-02-25 |
| 59651-0934-60 | 60 TABLET in 1 BOTTLE (59651-934-60) | everolimus | Aurobindo Pharma Limited | 2026-02-25 |
| 63850-0062-02 | 6 BLISTER PACK in 1 CARTON (63850-0062-2) / 10 TABLET in 1... | Everolimus | Natco Pharma Limited | 2021-05-20 |
| 63850-0062-06 | 60 TABLET in 1 BOTTLE (63850-0062-6) | Everolimus | Natco Pharma Limited | 2023-05-26 |
| 63850-0063-02 | 6 BLISTER PACK in 1 CARTON (63850-0063-2) / 10 TABLET in 1... | Everolimus | Natco Pharma Limited | 2021-05-20 |
| 63850-0063-06 | 60 TABLET in 1 BOTTLE (63850-0063-6) | Everolimus | Natco Pharma Limited | 2023-05-26 |
| 63850-0064-02 | 6 BLISTER PACK in 1 CARTON (63850-0064-2) / 10 TABLET in 1... | Everolimus | Natco Pharma Limited | 2021-05-20 |
| 63850-0064-06 | 60 TABLET in 1 BOTTLE (63850-0064-6) | Everolimus | Natco Pharma Limited | 2023-05-26 |
| 63850-0107-02 | 60 BLISTER PACK in 1 CARTON (63850-0107-2) / 10 TABLET in 1... | Everolimus | Natco Pharma Limited | 2025-10-14 |
| 63850-0107-03 | 60 TABLET in 1 BOTTLE (63850-0107-3) | Everolimus | Natco Pharma Limited | 2025-10-14 |
| 67877-0718-31 | 6 BLISTER PACK in 1 CARTON (67877-718-31) / 10 TABLET in 1... | Everolimus | Ascend Laboratories, LLC | 2021-11-27 |
| 67877-0718-60 | 60 TABLET in 1 BOTTLE (67877-718-60) | Everolimus | Ascend Laboratories, LLC | 2024-03-01 |
| 67877-0719-31 | 6 BLISTER PACK in 1 CARTON (67877-719-31) / 10 TABLET in 1... | Everolimus | Ascend Laboratories, LLC | 2021-11-27 |
| 67877-0719-60 | 60 TABLET in 1 BOTTLE (67877-719-60) | Everolimus | Ascend Laboratories, LLC | 2024-03-01 |
| 67877-0720-31 | 6 BLISTER PACK in 1 CARTON (67877-720-31) / 10 TABLET in 1... | Everolimus | Ascend Laboratories, LLC | 2021-11-27 |
| 67877-0720-60 | 60 TABLET in 1 BOTTLE (67877-720-60) | Everolimus | Ascend Laboratories, LLC | 2024-03-01 |
| 67877-0721-31 | 6 BLISTER PACK in 1 CARTON (67877-721-31) / 10 TABLET in 1... | Everolimus | Ascend Laboratories, LLC | 2021-11-27 |
| 67877-0721-60 | 60 TABLET in 1 BOTTLE (67877-721-60) | Everolimus | Ascend Laboratories, LLC | 2021-11-27 |
| 70377-0069-11 | 60 TABLET in 1 BOTTLE (70377-069-11) | Everolimus | Biocon Pharma Inc. | 2025-06-02 |
| 70377-0069-12 | 6 BLISTER PACK in 1 CARTON (70377-069-12) / 10 TABLET in 1... | Everolimus | Biocon Pharma Inc. | 2025-06-02 |
| 70377-0070-11 | 60 TABLET in 1 BOTTLE (70377-070-11) | Everolimus | Biocon Pharma Inc. | 2025-06-02 |
| 70377-0070-21 | 6 BLISTER PACK in 1 CARTON (70377-070-21) / 10 TABLET in 1... | Everolimus | Biocon Pharma Inc. | 2025-06-02 |
| 70377-0071-11 | 60 TABLET in 1 BOTTLE (70377-071-11) | Everolimus | Biocon Pharma Inc. | 2025-06-02 |
| 70377-0071-12 | 6 BLISTER PACK in 1 CARTON (70377-071-12) / 10 TABLET in 1... | Everolimus | Biocon Pharma Inc. | 2025-06-02 |
| 70377-0112-11 | 60 TABLET in 1 BOTTLE (70377-112-11) | Everolimus | Biocon Pharma Inc. | 2025-06-02 |
| 70377-0112-21 | 6 BLISTER PACK in 1 CARTON (70377-112-21) / 10 TABLET in 1... | Everolimus | Biocon Pharma Inc. | 2025-06-02 |
Observed labelers:
Ascend Laboratories, LLC (8) ·
Biocon Pharma Inc. (8) ·
Natco Pharma Limited (8) ·
Aurobindo Pharma Limited (4) ·
Hikma Pharmaceuticals USA Inc. (4) ·
Novartis Pharmaceuticals Corporation (4)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7527 | Oral everolimus | 19 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.